Skip to content

Medpace Voice

Tag: Radiopharmaceuticals

Clinical Development

SNMMI 2025 Highlights | Radiopharmaceuticals Reshaping Oncology Trials

  • July 1, 2025

Radiopharmaceuticals are reshaping oncology trials through integrated imaging, dosimetry, and therapeutic precision. Following SNMMI, Medpace experts share considerations for biopharma Sponsors navigating the scientific, operational,…

Clinical Development

Breast Cancer Awareness Month 2024

  • October 30, 2024

Breast cancer persists as a critical global health challenge, with an estimated 1 in 8 women facing a diagnosis over...

Company Spotlight

Breast Cancer Awareness Month

  • October 30, 2023

[New Webinar] In recognition of Breast Cancer Awareness Month, we unite to promote screening and prevention of breast cancer, which affects one in eight women…

Clinical Development

Emerging Trends in Radiopharmaceuticals

  • September 20, 2023

In July 2023, Medpace radiopharmaceutical experts attended the Annual Targeted Radiopharmaceuticals Summit US (TRP) in Boston, MA. Learn more from Senior Medical Director and Radiation…

Clinical Development

[Webinar] The Forefront of Radiopharmaceuticals

  • August 31, 2023

In a recent webinar, Medpace CRO is joined by an emerging biotech to discuss optimal approaches for alpha-RPT clinical trials. Watch now.